L773:0957 5235 OR L773:1473 5733
Search: L773:0957 5235 OR L773:1473 5733 > (1990-1994) > No transplacental p...
- 5 of 7
- Previous record
- Next record
- To hitlist
- Mätzsch, ThomasLund University,Lunds universitet,Institutionen för kliniska vetenskaper, Malmö,Medicinska fakulteten,Department of Clinical Sciences, Malmö,Faculty of Medicine (author)
No transplacental passage of standard heparin or an enzymatically depolymerized low molecular weight heparin
- Article/chapterEnglish1991
Publisher, publication year, extent ...
- 1991
Numbers
- LIBRIS-ID:oai:lup.lub.lu.se:1c67bf3c-f395-47f7-9c55-1379629de591
- https://lup.lub.lu.se/record/1105846URI
Supplementary language notes
- Language:English
- Summary in:English
Part of subdatabase
- SwePubSwePub
Classification
Notes
- In 21 women who had an abortion by hysterotomy between the 15th and 23rd week of pregnancy, the possibility that unfragmented heparin or low molecular weight heparin (LMWH) passed the placental barrier to the foetus was studied. Laboratory analyses included amidolytic assays of factor Xa inhibitory activity (XaI), antithrombin III (ATIII) and a direct measurement of heparin-like substances in plasma with a competitive binding assay. The ATIII concentration in foetal plasma was about 20% of that in normal human plasma and varied considerably between individuals (2-27%). The XaI activity did not differ between the two treated groups, but the mean XaI activity of the combined groups differed from zero (P less than 0.05). If the XaI activity was corrected for the ATIII concentration, the heparin activities no longer differed significantly from zero. As the concentration of heparin-like substances were above the detection limit (0.35 microgram/ml) in 6/16 analysable samples of foetal plasma, a further 15 women who had not received any heparin were included as controls. In 12/14 analysable foetal plasmas heparin-like substances in concentrations above 0.35 micrograms/ml could be detected. Determination of heparin activity in foetal plasma is thus difficult due to the influence of endogenous ATIII on heparin assays. In conclusion, this study did not demonstrate any evidence for the passage of heparin or LMWH across the placental barrier. No differences were detected whether unfragmented heparin or LMWH had been given to the mothers. Our results also indicate the presence of an endogenous glycosaminoglycan in foetal plasma.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
- Bergqvist, D (author)
- Bergqvist, A (author)
- Hodson, S (author)
- Dawes, J (author)
- Hedner, U (author)
- Ostergaard, P (author)
- Institutionen för kliniska vetenskaper, MalmöMedicinska fakulteten (creator_code:org_t)
Related titles
- In:Blood Coagulation and Fibrinolysis2:2, s. 273-2781473-5733
Internet link
Find in a library
- Blood Coagulation and Fibrinolysis (Search for host publication in LIBRIS)
To the university's database
- 5 of 7
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Mätzsch, Thomas
- Bergqvist, D
- Bergqvist, A
- Hodson, S
- Dawes, J
- Hedner, U
- show more...
- Ostergaard, P
- show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
- MEDICAL AND HEAL ...
- and Clinical Medicin ...
- and Hematology
- Articles in the publication
- Blood Coagulatio ...
- By the university
- Lund University
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
